Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 (1 Dimethylaminoethyl)phenol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101270058B details a high-yield hydrogenation route for 3-(1-dimethylaminoethyl)phenol, offering superior purity and cost efficiency for Alzheimer's drug intermediates.
Patent CN102264672A details a scalable route to chiral phenols using Ru-catalyzed transfer hydrogenation, offering cost reduction and high purity for pharmaceutical manufacturing.